DOCSLIB.ORG

Investigation of the Antibody Response and Nasal Shedding After EHV-1/4 Vaccination and Nasal Shedding of Gamma Herpesviruses

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Investigation of the Antibody Response and Nasal Shedding After EHV-1/4 Vaccination and Nasal Shedding of Gamma Herpesviruses Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2020 Investigation of the antibody response and nasal shedding after EHV-1/4 vaccination and nasal shedding of gamma herpesviruses Scheurer, Laura Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-200797 Dissertation Published Version Originally published at: Scheurer, Laura. Investigation of the antibody response and nasal shedding after EHV-1/4 vaccination and nasal shedding of gamma herpesviruses. 2020, University of Zurich, Vetsuisse Faculty. Departement für Pferde, Klinik für Pferdemedizin der Vetsuisse-Fakultät Universität Zürich Vorsteher: Prof. Dr. med. vet. Colin Schwarzwald Arbeit unter wissenschaftlicher Betreuung von PD Dr. med. vet. Angelika Schoster Investigation of the antibody response and nasal shedding after EHV-1/4 vaccination and nasal shedding of gamma herpesviruses Inaugural-Dissertation zur Erlangung der Doktorwürde der Vetsuisse-Fakultät Universität Zürich vorgelegt von Laura Scheurer Tierärztin von Schnottwil, Solothurn genehmigt auf Antrag von PD Dr. med. vet. Angelika Schoster, Referentin PD Dr. med. vet. Claudia Bachofen, Korreferentin 2020 3 Content Zusammenfassung ............................................................................................................... 6 Abstract ................................................................................................................................... 7 Glossary .................................................................................................................................. 8 1 Introduction ....................................................................................................................... 9 1.1 Herpesviruses .................................................................................................................. 9 1.1.1 Equine Herpesviruses ......................................................................................... 9 1.1.2 Equine Alpha Herpesviruses ............................................................................ 10 1.1.2.1 Virion ........................................................................................ 10 1.1.2.2 Epidemiology ............................................................................ 13 1.1.2.3 Seroprevalence .......................................................................... 13 1.1.2.4 Antigen (virus) prevalence ........................................................ 15 1.1.2.5 Latency ...................................................................................... 16 1.1.2.6 Transmission ............................................................................. 17 1.1.2.7 Pathogenesis of EHV-1 and -4 in general ................................ 19 1.1.2.8 Respiratory Disease .................................................................. 20 1.1.2.9 Abortion, Neonatal and Perinatal Disease ............................... 21 1.1.2.10 Myeloencephalopathy ............................................................. 21 1.1.2.11 Occular Disease ...................................................................... 22 1.1.2.12 Diagnosis of EHV-1 and -4 ..................................................... 22 1.1.2.13 Immunity against EHV ............................................................ 23 1.1.2.14 Vaccination ............................................................................. 24 1.1.3 Equine Gamma Herpesviruses ......................................................................... 30 1.1.3.1 Genomic structure ..................................................................... 30 1.1.3.2 Epidemiology ............................................................................ 31 1.1.3.3 Pathogenesis and Clinical signs ............................................... 31 1.1.3.4 Diagnosis of infection ............................................................... 33 1.1.4 Aims and Hypothesis of the Study ................................................................... 33 2 Material and Methods .................................................................................................. 34 2.1 PART – A EHV-1 and EHV-4 shedding and antibody response after vaccination 34 2.1.1 Farms and animals ............................................................................................ 34 4 2.1.2 Vaccination ....................................................................................................... 35 2.1.3 Sampling ........................................................................................................... 36 2.1.3.1 Sampling procedure .................................................................. 38 2.1.4 DNA detection EHV-1 and EHV-4 (real - time PCR) ..................................... 39 2.1.5 EHV-1 and EHV-4 antibody detection (ELISA) ............................................. 41 2.1.6 Statistical analysis ............................................................................................ 42 2.2 PART – B Screening for equine herpesviruses in healthy horses ........................... 43 2.2.1 Farms and animals ............................................................................................ 43 2.2.2 Panherpes nested PCR ...................................................................................... 44 2.2.3 Statistical analysis ............................................................................................ 46 3 Results ................................................................................................................................ 47 3.1 PART – A EHV-1 and EHV-4 shedding and antibody response after vaccination 47 3.1.1 Animals ............................................................................................................ 47 3.1.2 Adverse reaction to the vaccine ........................................................................ 49 3.1.3 EHV outbreak in Control Group D .................................................................. 49 3.1.4 Serological EHV-1 response after vaccination................................................. 49 3.1.4.1 Pre-study antibody status .......................................................... 49 3.1.4.2 Serological results of sample groups ........................................ 49 3.1.4.3 Serological results of single animals ........................................ 52 3.1.4.4 Group A – Basic immunization > 4 years ago with boosters every 6 months .......................................................................... 53 3.1.4.5 Group B – no vaccination history, vaccinated twice 6 months apart .......................................................................................... 54 3.1.4.6 Group C – no vaccination history, vaccinated with BI followed by a booster 6 months later ....................................................... 55 3.1.4.7 Group D – No vaccination history, natural exposure............... 56 3.1.5 Serological EHV-4 response after vaccination................................................. 57 3.1.5.1 Serologic results of single animals ........................................... 57 3.1.5.2 Group A – Basic immunization > 4 years ago with boosters every 6 months........................................................................... 58 3.1.5.3 Group B – no vaccination history, vaccinated twice 6 months apart .......................................................................................... 59 3.1.5.4 Group C – no vaccination history, vaccinated with BI followed by a booster 6 months later ....................................................... 60 3.1.5.5 Group D – No vaccination history, natural exposure............... 61 3.1.6 Viral shedding at pre-study status .................................................................... 62 5 3.1.6.1 EHV-1 Contamination of pre-vaccination samples by vaccine vials ........................................................................................... 62 3.1.7 EHV-1 viral shedding after vaccination ........................................................... 63 3.1.7.1 Viral shedding results of sample groups ................................... 63 3.1.7.2 Viral shedding results of single animals ................................... 65 3.1.7.3 Group A – Basic immunization > 4 years ago with boosters every 6 months........................................................................... 66 3.1.7.4 Group B – no vaccination history, vaccinated twice 6 months apart .......................................................................................... 67 3.1.7.5 Group C – no vaccination history, vaccinated with BI followed by a booster 6 months later ....................................................... 68 3.1.7.6 Group D – No vaccination history, natural exposure............... 69 3.1.8 EHV-4 viral shedding after vaccination ........................................................... 70 3.1.8.1 Viral shedding results of sample groups ................................... 70 3.1.8.2 Viral shedding results of single animals ................................... 72 3.1.8.3 Group A – Basic immunization > 4 years ago with boosters every 6 months........................................................................... 73 3.1.8.4 Group B – no vaccination history, vaccinated twice 6 months apart .........................................................................................
Load more

Recommended publications
  • Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood
    pathogens Article Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection Lila M. Zarski 1, Patty Sue D. Weber 2, Yao Lee 1 and Gisela Soboll Hussey 1,* 1 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA; [email protected] (L.M.Z.); [email protected] (Y.L.) 2 Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; [email protected] * Correspondence: [email protected] Abstract: Equine herpesvirus 1 (EHV-1) affects horses worldwide and causes respiratory dis- ease, abortions, and equine herpesvirus myeloencephalopathy (EHM). Following infection, a cell- associated viremia is established in the peripheral blood mononuclear cells (PBMCs). This viremia is essential for transport of EHV-1 to secondary infection sites where subsequent immunopathol- ogy results in diseases such as abortion or EHM. Because of the central role of PBMCs in EHV-1 pathogenesis, our goal was to establish a gene expression analysis of host and equine herpesvirus genes during EHV-1 viremia using RNA sequencing. When comparing transcriptomes of PBMCs during peak viremia to those prior to EHV-1 infection, we found 51 differentially expressed equine genes (48 upregulated and 3 downregulated). After gene ontology analysis, processes such as the interferon defense response, response to chemokines, the complement protein activation cascade, cell adhesion, and coagulation were overrepresented during viremia. Additionally, transcripts for EHV-1, EHV-2, and EHV-5 were identified in pre- and post-EHV-1-infection samples. Looking at Citation: Zarski, L.M.; Weber, P.S.D.; micro RNAs (miRNAs), 278 known equine miRNAs and 855 potentially novel equine miRNAs were Lee, Y.; Soboll Hussey, G.
    [Show full text]
  • Valproic Acid and Its Amidic Derivatives As New Antivirals Against Alphaherpesviruses
    viruses Review Valproic Acid and Its Amidic Derivatives as New Antivirals against Alphaherpesviruses Sabina Andreu 1,2,* , Inés Ripa 1,2, Raquel Bello-Morales 1,2 and José Antonio López-Guerrero 1,2 1 Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; [email protected] (I.R.); [email protected] (R.B.-M.); [email protected] (J.A.L.-G.) 2 Centro de Biología Molecular Severo Ochoa, Spanish National Research Council—Universidad Autónoma de Madrid (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain * Correspondence: [email protected] Academic Editor: Maria Kalamvoki Received: 14 November 2020; Accepted: 25 November 2020; Published: 26 November 2020 Abstract: Herpes simplex viruses (HSVs) are neurotropic viruses with broad host range whose infections cause considerable health problems in both animals and humans. In fact, 67% of the global population under the age of 50 are infected with HSV-1 and 13% have clinically recurrent HSV-2 infections. The most prescribed antiherpetics are nucleoside analogues such as acyclovir, but the emergence of mutants resistant to these drugs and the lack of available vaccines against human HSVs has led to an imminent need for new antivirals. Valproic acid (VPA) is a branched short-chain fatty acid clinically used as a broad-spectrum antiepileptic drug in the treatment of neurological disorders, which has shown promising antiviral activity against some herpesviruses. Moreover, its amidic derivatives valpromide and valnoctamide also share this antiherpetic activity. This review summarizes the current research on the use of VPA and its amidic derivatives as alternatives to traditional antiherpetics in the fight against HSV infections.
    [Show full text]
  • Faculdade De Medicina Veterinária
    UNIVERSIDADE DE LISBOA Faculdade de Medicina Veterinária FIBROPAPILLOMATOSIS AND THE ASSOCIATED CHELONID HERPESVIRUS 5 IN GREEN TURTLES FROM WEST AFRICA JESSICA CORREIA MONTEIRO CONSTITUIÇÃO DO JÚRI ORIENTADORA Doutor Luís Manuel Morgado Tavares Doutora Ana Isabel Simões Pereira Duarte Doutora Ana Isabel Simões Pereira Duarte CO-ORIENTADORA Doutor José Alexandre da Costa Perdigão e Doutora Ana Rita Caldas Patrício Cameira Leitão 2019 LISBOA This thesis was financed by Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA) of the Faculty of Veterinary Medicine, University of Lisbon. The fieldwork was funded by a grant from the MAVA foundation attributed to the Institute of Biodiversity and Protected Areas from Guinea-Bissau. The investigation was carried out at the Virology Laboratory of Instituto Nacional de Investigação Agrária e Veterinária (INIAV) under the supervision of Doctor Margarida Duarte and Doctor Ana Duarte. UNIVERSIDADE DE LISBOA Faculdade de Medicina Veterinária FIBROPAPILLOMATOSIS AND THE ASSOCIATED CHELONID HERPESVIRUS 5 IN GREEN TURTLES FROM WEST AFRICA JESSICA CORREIA MONTEIRO DISSERTAÇÃO DE MESTRADO INTEGRADO EM MEDICINA VETERINÁRIA CONSTITUIÇÃO DO JÚRI ORIENTADORA Doutor Luís Manuel Morgado Tavares Doutora Ana Isabel Simões Pereira Duarte Doutora Ana Isabel Simões Pereira Duarte CO-ORIENTADORA Doutora Ana Rita Caldas Patrício Doutor José Alexandre da Costa Perdigão e Cameira Leitão 2019 LISBOA To my mother and grandfather, for giving me everything ii ACKNOWLEGDEMENTS First of all I’d like to thank my mother, not only for taking care of me all these years, but also for pushing me in the right direction. If it wasn’t for you I wouldn’t have been able to fulfil my life long dream.
    [Show full text]
  • A Scoping Review of Viral Diseases in African Ungulates
    veterinary sciences Review A Scoping Review of Viral Diseases in African Ungulates Hendrik Swanepoel 1,2, Jan Crafford 1 and Melvyn Quan 1,* 1 Vectors and Vector-Borne Diseases Research Programme, Department of Veterinary Tropical Disease, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa; [email protected] (H.S.); [email protected] (J.C.) 2 Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium * Correspondence: [email protected]; Tel.: +27-12-529-8142 Abstract: (1) Background: Viral diseases are important as they can cause significant clinical disease in both wild and domestic animals, as well as in humans. They also make up a large proportion of emerging infectious diseases. (2) Methods: A scoping review of peer-reviewed publications was performed and based on the guidelines set out in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews. (3) Results: The final set of publications consisted of 145 publications. Thirty-two viruses were identified in the publications and 50 African ungulates were reported/diagnosed with viral infections. Eighteen countries had viruses diagnosed in wild ungulates reported in the literature. (4) Conclusions: A comprehensive review identified several areas where little information was available and recommendations were made. It is recommended that governments and research institutions offer more funding to investigate and report viral diseases of greater clinical and zoonotic significance. A further recommendation is for appropriate One Health approaches to be adopted for investigating, controlling, managing and preventing diseases. Diseases which may threaten the conservation of certain wildlife species also require focused attention.
    [Show full text]
  • Repurposing the Human Immunodeficiency Virus (Hiv) Integrase
    REPURPOSING THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE INHIBITOR RALTEGRAVIR FOR THE TREATMENT OF FELID ALPHAHERPESVIRUS 1 (FHV-1) OCULAR INFECTION A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Matthew Robert Pennington August 2018 © 2018 Matthew Robert Pennington REPURPOSING THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE INHIBITOR RALTEGRAVIR FOR THE TREATMENT OF FELID ALPHAHERPESVIRUS 1 (FHV-1) OCULAR INFECTION Matthew Robert Pennington, Ph.D. Cornell University 2018 Herpesviruses infect many species, inducing a wide range of diseases. Herpesvirus- induced ocular disease, which may lead to blindness, commonly occurs in humans, dogs, and cats, and is caused by human alphaherpesvirus 1 (HHV-1), canid alphaherpesvirus (CHV-1), and felid alphaherpesvirus 1 (FHV-1), respectively. Rapid and effective antiviral therapy is of the utmost importance to control infection in order to preserve the vision of infected people or animals. However, current treatment options are suboptimal, in large part due to the difficulty and cost of de novo drug development and the lack of effective models to bridge work in in vitro cell cultures and in vivo. Repurposing currently approved drugs for viral infections is one strategy to more rapidly identify new therapeutics. Furthermore, studying ocular herpesviruses in cats is of particular importance, as this condition is a frequent disease manifestation in these animals and FHV-1 infection of the cat is increasingly being recognized as a valuable natural- host model of herpesvirus-induced ocular infection First, the current models to study ocular herpesvirus infections were reviewed.
    [Show full text]
  • Breeder Demographic Survey and Molecular Period Prevalence of Equid Alphaherpesvirus 1 in Healthy Ontario Broodmares
    Breeder Demographic Survey and Molecular Period Prevalence of Equid Alphaherpesvirus 1 in Healthy Ontario Broodmares by Carina J. Cooper A Thesis presented to The University of Guelph In partial fulfilment of requirements for the degree of Doctor of Philosophy in Pathobiology Guelph, Ontario, Canada © Carina Cooper, September 2020 ABSTRACT BREEDER DEMOGRAPHIC SURVEY AND MOLECULAR PERIOD PREVALENCE OF EQUID ALPHAHERPESVIRUS 1 IN HEALTHY ONTARIO BROODMARES Carina J. Cooper Advisors: University of Guelph, 2020 Brandon N. Lillie Luis G. Arroyo Equid alphaherpesvirus 1 (EHV-1) causes disease in all ages of horses, from abortion and neonatal death to encephalomyelopathy in adults. The main objective of this thesis was to investigate the current opinions of breeders in Ontario, provide prevalence estimates, and describe current vaccine use for EHV-1, which have not been studied. A survey of 88 breeders in Ontario indicated 72.7 % currently vaccinate their herds, and most consult veterinarians for assistance only when encountering abortions, not respiratory disease. Most herds were vaccinated either twice annually or using a “pre-foaling protocol”. In a follow up study, a period prevalence estimate was generated by sampling 381 broodmares from 42 farms across Ontario every two months from December 2016 through October 2017. Samples were collected from the nose, blood and vaginal mucosa and analysed using droplet digital PCR (ddPCR). A total of 85.0 % of broodmares were positive for EHV-1 at some point during the sampling period, and vagina was identified as a source of EHV-1, with viral DNA collected more often from the vagina than the nose. Using mixed logistic regression models, we found no association between virus presence and age or breed.
    [Show full text]
  • Avian Viral Surveillance in Victoria, Australia, and Detection of Two Novel Avian Herpesviruses
    RESEARCH ARTICLE Avian viral surveillance in Victoria, Australia, and detection of two novel avian herpesviruses Jemima Amery-Gale1,2*, Carol A. Hartley1, Paola K. Vaz1, Marc S. Marenda3, Jane Owens1, Paul A. Eden2, Joanne M. Devlin1 1 Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia, 2 Australian Wildlife Health Centre, Healesville Sanctuary, Zoos Victoria, Badger Creek, Victoria, Australia, 3 Asia-Pacific Centre for Animal a1111111111 Health, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of a1111111111 Melbourne, Werribee, Victoria, Australia a1111111111 a1111111111 * [email protected] a1111111111 Abstract Viruses in avian hosts can pose threats to avian health and some have zoonotic potential. OPEN ACCESS Hospitals that provide veterinary care for avian patients may serve as a site of exposure Citation: Amery-Gale J, Hartley CA, Vaz PK, of other birds and human staff in the facility to these viruses. They can also provide a use- Marenda MS, Owens J, Eden PA, et al. (2018) ful location to collect samples from avian patients in order to examine the viruses present Avian viral surveillance in Victoria, Australia, and detection of two novel avian herpesviruses. PLoS in wild birds. This study aimed to investigate viruses of biosecurity and/or zoonotic signifi- ONE 13(3): e0194457. https://doi.org/10.1371/ cance in Australian birds by screening samples collected from 409 birds presented to the journal.pone.0194457 Australian Wildlife Health Centre at Zoos Victoria's Healesville Sanctuary for veterinary Editor: Jonas WaldenstroÈm, Linnaeus University, care between December 2014 and December 2015.
    [Show full text]
  • Viral Equine Encephalitis, a Growing Threat
    Viral Equine Encephalitis, a Growing Threat to the Horse Population in Europe? Sylvie Lecollinet, Stéphane Pronost, Muriel Coulpier, Cécile Beck, Gaëlle Gonzalez, Agnès Leblond, Pierre Tritz To cite this version: Sylvie Lecollinet, Stéphane Pronost, Muriel Coulpier, Cécile Beck, Gaëlle Gonzalez, et al.. Viral Equine Encephalitis, a Growing Threat to the Horse Population in Europe?. Viruses, MDPI, 2019, 12 (1), pp.23. 10.3390/v12010023. hal-02425366 HAL Id: hal-02425366 https://hal-normandie-univ.archives-ouvertes.fr/hal-02425366 Submitted on 23 Apr 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License viruses Review Viral Equine Encephalitis, a Growing Threat to the Horse Population in Europe? Sylvie Lecollinet 1,2,* , Stéphane Pronost 2,3,4, Muriel Coulpier 1,Cécile Beck 1,2 , Gaelle Gonzalez 1, Agnès Leblond 5 and Pierre Tritz 2,6,7 1 UMR (Unité Mixte de Recherche) 1161 Virologie, Anses (the French Agency for Food, Environmental and Occupational Health and Safety), INRAE
    [Show full text]
  • Failure to Detect Equid Herpesvirus Type 1 DNA in Thoroughbred Placentae and Healthy New-Born Foals
    Failure to detect equid herpesvirus type 1 DNA in Thoroughbred placentae and healthy new-born foals Principal researcher: Dr Lara Jean Brown Supervisor: Dr Geoff Brown, University of Pretoria, RSA Co-supervisor: Prof Martin Schulman, University of Pretoria, RSA Co-supervisor: Dr Julia Kydd, University of Nottingham, UK Co-supervisor: Prof Tom Stout, Utrecht University, Netherlands Declaration of originality I, Lara Jean Brown, do hereby declare that the research presented in this dissertation was conceived and executed by myself, and apart from the normal guidance of my supervisor, I have received no assistance. Neither the substance, nor any part of this dissertation, has been submitted in the past, nor is to be submitted for a degree at this university, nor any other university. This dissertation is presented in fulfilment of the requirements for the MSc (Production Animal Science) in the department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria. I hereby grant the University of Pretoria free licence to reproduce this dissertation, in part or as a whole, for the purpose of research or continuing education. 31/10/2017 Lara Jean Brown Date i Acknowledgements I would like to thank all who have assisted me with this project through giving their advice, time and expertise. I would particularly like to thank the following people: My supervisors, Dr Geoff Brown, Prof Martin Schulman, Dr Julia Kydd and Prof Tom Stout for their guidance during the sample collection period and for their support and guidance during the writing up of this thesis. Prof Alan Guthrie for his guidance and assistance in the setting up of our sampling protocol and during the data analysis period.
    [Show full text]
  • Documento Completo Descargar Archivo
    UNIVERSIDAD NACIONAL DE LA PLATA FACULTAD DE CIENCIAS VETERINARIAS Trabajo de Tesis realizado como requisito para optar al título de DOCTOR EN CIENCIAS VETERINARIAS RESPUESTA INMUNE LOCAL EN LA PATOGENIA DEL ABORTO INDUCIDO POR HERPESVIRUS EQUINO 1 Autor: Méd. Vet. BRAVI María Emilia DIRECTORAS: Dra. Galosi Cecilia M. y Dra. Zanuzzi Carolina N. Cátedras de Virología e Histología y Embriología. FCV-UNLP Miembros del jurado: Dra. Dolcini Guillermina Dra. Monteavaro Cristina Dra. Rambeaud Magdalena 2018 II A mis hijos, Catalina y Ciro Bravi, María Emilia III De todo quedaron tres cosas: la certeza de que estaba siempre comenzando, la certeza de que había que seguir y la certeza de que sería interrumpido antes de terminar. Hacer de la interrupción un camino nuevo, hacer de la caída, un paso de danza, del miedo, una escalera, del sueño, un puente, de la búsqueda,…un encuentro. Fernando Pessoa Bravi, María Emilia IV Agradecimientos En primer lugar quiero agradecer a mis directores, quienes me guiaron y siempre tuvieron gran dedicación y compromiso para transmitir sus conocimientos, formando un excelente grupo de trabajo, pero sobretodo de personas y a quienes admiro muchísimo por su trayectoria; A Ceci, por darme la oportunidad de conocer el mundo de la investigación y por confiar en mí, por ponerle amor antes que todo, amor a lo que uno hace y con quien trabaja, enseñando con el ejemplo. Por ser tan buena persona y comprensiva, por sus sabias palabras y grandes consejos. Para mí fue un orgullo ser su becaria; la última de un largo camino. A Caro, por brindarme su apoyo y honestidad, por sus consejos y el tiempo que dedicó siempre con gran responsabilidad, compromiso y cariño.
    [Show full text]
  • Molecular Surveillance of EHV-1 Strains Circulating in France During and After the Major 2009 Outbreak in Normandy Involving
    Article Molecular Surveillance of EHV-1 Strains Circulating in France during and after the Major 2009 Outbreak in Normandy Involving Respiratory Infection, Neurological Disorder, and Abortion Gabrielle Sutton 1,2,*, Marie Garvey 3, Ann Cullinane 3, Marion Jourdan 4, Christine Fortier 1,2, Peggy Moreau 5, Marc Foursin 5, Annick Gryspeerdt 6, Virginie Maisonnier 4, Christel Marcillaud-Pitel 4, Loïc Legrand 1,2, Romain Paillot 1,2,† and Stéphane Pronost 1,2,† 1 LABÉO Frank Duncombe, 14280 Saint-Contest, France; [email protected] (C.F.); [email protected] (L.L.); [email protected] (R.P.); [email protected] (S.P.) 2 NORMANDIE UNIV, UNICAEN, BIOTARGEN, 14000 Caen, France 3 Irish Equine Centre, Johnstown, Naas, County Kildare, W91 RH93, Ireland; [email protected] (M.G.); [email protected] (A.C.); 4 RESPE, 14280 Saint-Contest, France; [email protected] (M.J.); [email protected] (V.M.); [email protected] (C.M.-P.); 5 Clinique équine de la Boisrie, 61500, Chailloué, France; [email protected] (P.M.); [email protected] (M.F.); 6 Equi Focus Point Belgium, 8900 Ypres, Belgium; [email protected] ; † The authors have contributed equally to the work * Correspondence: [email protected] ; Tel.: +33 2 31 41 93 61 Received: 14 August 2019; Accepted: 1 October 2019; Published: 4 October 2019 Abstract: Equine herpesvirus 1 (EHV-1) is an Alphaherpesvirus infecting not only horses but also other equid and non-equid mammals. It can cause respiratory distress, stillbirth and neonatal death, abortion, and neurological disease.
    [Show full text]
  • Mardivirus), but Not the Host (Gallid
    viruses Article The Requirement of Glycoprotein C for Interindividual Spread Is Functionally Conserved within the Alphaherpesvirus Genus (Mardivirus), but Not the Host (Gallid) Widaliz Vega-Rodriguez 1 , Nagendraprabhu Ponnuraj 1, Maricarmen Garcia 2 and Keith W. Jarosinski 1,* 1 Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA; [email protected] (W.V.-R.); [email protected] (N.P.) 2 Poultry Diagnostic and Research Center, Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-217-300-4322 Abstract: Marek’s disease (MD) in chickens is caused by Gallid alphaherpesvirus 2, better known as MD herpesvirus (MDV). Current vaccines do not block interindividual spread from chicken-to- chicken, therefore, understanding MDV interindividual spread provides important information for the development of potential therapies to protect against MD, while also providing a natural host to study herpesvirus dissemination. It has long been thought that glycoprotein C (gC) of alphaherpesviruses evolved with their host based on their ability to bind and inhibit complement in a species-selective manner. Here, we tested the functional importance of gC during interindividual spread and host specificity using the natural model system of MDV in chickens through classical compensation experiments. By exchanging MDV gC with another chicken alphaherpesvirus (Gallid Citation: Vega-Rodriguez, W.; alphaherpesvirus 1 or infectious laryngotracheitis virus; ILTV) gC, we determined that ILTV gC Ponnuraj, N.; Garcia, M.; Jarosinski, could not compensate for MDV gC during interindividual spread. In contrast, exchanging turkey K.W.
    [Show full text]